Could outcomes of intracranial aneurysms be better predict using serum creatinine and glomerular filtration rate?
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ACTA CIRURGICA BRASILEIRA
Citação
ACTA CIRURGICA BRASILEIRA, v.37, n.1, article ID e370107, 11p, 2022
Resumo
Purpose: To analyze the role of serum creatinine levels as a biomarker of intracranial aneurysm outcomes. Methods: This is a prospective analysis of outcomes of patients with intracranial aneurysm. One hundred forty-seven patients with serum creatinine at admission and 6 months follow up were included. Linear and logistic regressions were used to analyze the data. Modified Rankin scale (mRS) was used to assess outcome. Results: Creatinine level was not directly related to aneurysm outcome nor aneurysm rupture (p > 0.05). However, patients with a glomerular filtration rate (GFR) lower than 72.50 mL.min(-1) had an odds ratio (OR) of 3.049 (p = 0.006) for worse outcome. Similarly, aneurysm rupture had an OR of 2.957 (p = 0.014) for worse outcomes. Stepwise selection model selected 4 variables for outcomes prediction: serum creatinine, sex, hypertension and treatment. Hypertensive patients had, on average, an increase in 0.588 in mRS (p = 0.022), while treatment with microsurgery had a decrease in 0.555 (p = 0.038). Conclusion: Patients with higher GFR had better outcomes after 6 months. Patients with higher GFR had better outcomes after 6 months. Creatinine presented an indirect role in GFR values and should be included in models for outcome prediction.
Palavras-chave
Creatinine, Intracranial Aneurysm, Glomerular Filtration Rate
Referências
- Alves CRR, 2020, NEUROLOGY, V94, pE921, DOI 10.1212/WNL.0000000000008762
- BONITA R, 1986, STROKE, V17, P831, DOI 10.1161/01.STR.17.5.831
- Chalouhi N, 2015, DNA CELL BIOL, V34, P78, DOI 10.1089/dna.2014.2618
- Coresh J, 2019, CLIN J AM SOC NEPHRO, V14, P792, DOI 10.2215/CJN.04160419
- de Boer RA, 2018, JAMA CARDIOL, V3, P215, DOI 10.1001/jamacardio.2017.4987
- De Rosa S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1218-4
- Toledo P, 2009, IEEE T INF TECHNOL B, V13, P794, DOI 10.1109/TITB.2009.2020434
- de Torres R, 2020, FUTUR SCI OA, V6, DOI 10.2144/fsoa-2019-0090
- Etminan N, 2019, JAMA NEUROL, V76, P588, DOI 10.1001/jamaneurol.2019.0006
- FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001
- Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B
- Fuernau G, 2019, CURR OPIN CRIT CARE, V25, P403, DOI 10.1097/MCC.0000000000000628
- Fukuyama T, 2018, BRAIN DEV-JPN, V40, P707, DOI 10.1016/j.braindev.2018.04.005
- George JA, 2019, ADV CLIN CHEM, V88, P91, DOI 10.1016/bs.acc.2018.10.005
- Goldberg J, 2018, STROKE, V49, P2883, DOI 10.1161/STROKEAHA.118.022869
- Gounis MJ, 2014, STROKE, V45, P1474, DOI 10.1161/STROKEAHA.114.004956
- Harrod CG, 2006, MED HYPOTHESES, V66, P736, DOI 10.1016/j.mehy.2005.09.051
- Hijazi Z, 2016, LANCET, V387, P2302, DOI 10.1016/S0140-6736(16)00741-8
- Hijikata Y, 2016, ANN CLIN TRANSL NEUR, V3, P537, DOI 10.1002/acn3.324
- Hostettler IC, 2018, J NEUROSURG, V129, P1499, DOI 10.3171/2017.7.JNS17677
- Huang RL, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.06.018
- Hussain S, 2015, WORLD NEUROSURG, V84, P1473, DOI 10.1016/j.wneu.2015.06.034
- Ironside N, 2019, WORLD NEUROSURG, V125, pE723, DOI 10.1016/j.wneu.2019.01.162
- Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052
- Kamil Faiz Fathima Z, 2018, Proc (Bayl Univ Med Cent), V31, P276, DOI 10.1080/08998280.2018.1446637
- Kao HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132115
- Kazory A, 2019, BLOOD PURIFICAT, V48, P193, DOI 10.1159/000500409
- Konczalla J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-140
- Kundra Sandeep, 2014, J Anaesthesiol Clin Pharmacol, V30, P328, DOI 10.4103/0970-9185.137261
- Lafleur J, 2018, ANTICANCER RES, V38, P5127, DOI 10.21873/anticanres.12834
- Lankisch PG, 2010, AM J GASTROENTEROL, V105, P1196, DOI 10.1038/ajg.2009.688
- Lassnigg A, 2008, CRIT CARE MED, V36, P1129, DOI 10.1097/CCM.0b013e318169181a
- Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602
- Li YP, 2019, NEUROSURGERY, V84, P1261, DOI 10.1093/neuros/nyy182
- Lindgren AE, 2014, ANN MED, V46, P169, DOI 10.3109/07853890.2014.883168
- Liu JJ, 2020, NEUROSURGERY, V87, P523, DOI 10.1093/neuros/nyaa052
- Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7
- Menghini VV, 1998, NEUROLOGY, V51, P405, DOI 10.1212/WNL.51.2.405
- Norris KC, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0821-9
- Panotopoulos J, 2016, J ORTHOP RES, V34, P533, DOI 10.1002/jor.23002
- Petridis AK, 2017, DTSCH ARZTEBL INT, V114, P226, DOI 10.3238/arztebl.2017.0226
- Rose MJ, 2011, CURR OPIN ANESTHESIO, V24, P500, DOI 10.1097/ACO.0b013e32834ad45b
- Rubbert C, 2018, EUR RADIOL, V28, P4949, DOI 10.1007/s00330-018-5505-0
- Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070
- van Donkelaar CE, 2019, STROKE, V50, P837, DOI 10.1161/STROKEAHA.118.023902
- van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6
- Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0
- Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3
- Wang L, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00196
- Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401
- Willegger M, 2017, J ORTHOP RES, V35, P2815, DOI 10.1002/jor.23598
- Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923
- Zhang HF, 2013, INFLAMMATION, V36, P1195, DOI 10.1007/s10753-013-9655-6
- Zheng K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00123
- Zyczkowski M, 2018, MED SCI MONITOR, V24, P3895, DOI 10.12659/MSM.906867